An open-access article in ARRS'American Journal of Roentgenology(AJR) established a foundation for the use of virtual imaging trials in effective assessment and optimization of CT and radiography acquisitions and analysis tools to help manage the coronavirus disease (COVID-19) pandemic.
Virtual imaging trials have two main components--representative models of targeted subjects and realistic models of imaging scanners--and the authors of thisAJRarticle developed the first computational models of patients with COVID-19, while showing, as proof of principle, how they can be combined with imaging simulators for COVID-19 imaging studies.
"For the body habitus of the models," lead author Ehsan Abadi explained, "we used the 4D extended cardiac-torso (XCAT) model that was developed at Duke University."
Abadi and his Duke colleagues then segmented the morphologic features of COVID-19 abnormalities from 20 CT images of patients with multidiagnostic confirmation of SARS-CoV-2 infection and incorporated them into XCAT models.
"Within a given disease area, the texture and material of the lung parenchyma in the XCAT were modified to match the properties observed in the clinical images," Abadi et al. continued.
Using a specific CT scanner (Definition Flash, Siemens Healthineers) and validated radiography simulator (DukeSim) to help illustrate utility, the team virtually imaged three developed COVID-19 computational phantoms.
"Subjectively," the authors concluded, "the simulated abnormalities were realistic in terms of shape and texture," adding their preliminary results showed that the contrast-to-noise ratios in the abnormal regions were 1.6, 3.0, and 3.6 for 5-, 25-, and 50-mAs images, respectively.
Story Source:
Materialsprovided byAmerican Roentgen Ray Society.注意:内容可能被编辑风格d length.
Journal Reference:
Cite This Page: